UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):  October 19, 2012


GALTECH SEMICONDUCTOR MATERIALS CORPORATION
(Exact name of registrant as specified in its charter)
         
Utah
 
0-27177
 
87-0427597
(State or other jurisdiction of
 
(Commission File Number)
 
(IRS Employer
incorporation or organization)
     
Identification No.)
         
2984-G Austin Springs Blvd.
   
Miamisburg, OH
 
45342
(Address of principal executive offices)
 
(Zip code)
     
Registrant’s telephone number, including area code:
 
(281) 415-4121
     
N/A
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 

 


Item 5.02 — Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

A special meeting of the Board of Directors was held on October 19, 2012 and removed William Tunnell as a Board member effective immediately. Mr. Tunnell remains an officer of Galtech as Senior Vice President of Mergers and Acquisitions

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
GALTECH SEMICONDUCTOR MATERIALS CORPORATION
 
Registrant
     
     
Dated: October 22, 2012
By:
/s/ Dr. Frank N. Kautzmann, III
   
Dr. Frank N. Kautzmann, III,  Chairman, CEO and President


2